Bioceres Crop Solutions Corp.
NASDAQ:BIOX
6.84 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 464.829 | 419.446 | 328.456 | 206.698 | 172.351 | 160.309 | 133.491 | 93.707 | 5.1 |
| Cost of Revenue
| 282.398 | 239.198 | 202.019 | 115.816 | 92.859 | 86.685 | 77.095 | 59.859 | 3.88 |
| Gross Profit
| 182.431 | 180.249 | 126.437 | 90.882 | 79.492 | 73.624 | 56.397 | 33.848 | 1.22 |
| Gross Profit Ratio
| 0.392 | 0.43 | 0.385 | 0.44 | 0.461 | 0.459 | 0.422 | 0.361 | 0.239 |
| Reseach & Development Expenses
| 17.183 | 15.345 | 6.947 | 5.618 | 4.195 | 3.689 | 3.95 | 3.981 | 0.303 |
| General & Administrative Expenses
| 77.45 | 70.226 | 42.99 | 29.829 | 23.746 | 25.976 | 33.024 | 25.292 | 1.143 |
| Selling & Marketing Expenses
| 16.817 | 16.711 | 16.031 | 7.41 | 5.731 | 4.862 | 2.24 | 2.095 | 0.091 |
| SG&A
| 106.972 | 86.937 | 59.021 | 37.238 | 29.476 | 30.837 | 35.264 | 27.388 | 1.234 |
| Other Expenses
| 12.614 | -0.221 | -0.293 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 136.768 | 125.936 | 86.113 | 52.936 | 41.324 | 41.833 | 38.549 | 41.32 | 1.034 |
| Operating Income
| 44.821 | 54.184 | 39.87 | 38.383 | 39.146 | 32.086 | 15.711 | -0.707 | -0.335 |
| Operating Income Ratio
| 0.096 | 0.129 | 0.121 | 0.186 | 0.227 | 0.2 | 0.118 | -0.008 | -0.066 |
| Total Other Income Expenses Net
| -34.785 | -35.078 | -25.806 | -27.852 | -32.703 | -41.458 | -40.951 | -20.387 | -0.168 |
| Income Before Tax
| 10.035 | 19.106 | 14.064 | 10.531 | 6.443 | -9.373 | -25.24 | -22.392 | -0.503 |
| Income Before Tax Ratio
| 0.022 | 0.046 | 0.043 | 0.051 | 0.037 | -0.058 | -0.189 | -0.239 | -0.099 |
| Income Tax Expense
| 3.779 | -1.069 | 17.973 | 14.351 | 2.207 | 6.986 | -10.929 | 5.635 | 0.691 |
| Net Income
| 3.243 | 18.78 | -7.2 | -6.87 | 3.359 | -18.369 | -11.04 | -11.818 | -1.194 |
| Net Income Ratio
| 0.007 | 0.045 | -0.022 | -0.033 | 0.019 | -0.115 | -0.083 | -0.126 | -0.234 |
| EPS
| 0.052 | 0.3 | -0.17 | -0.18 | 0.093 | -0.6 | -0.39 | -0.42 | 0 |
| EPS Diluted
| 0.051 | 0.3 | -0.17 | -0.18 | 0.092 | -0.6 | -0.39 | -0.42 | 0 |
| EBITDA
| 54.153 | 61.086 | 40.033 | 37.038 | 29.58 | 17.291 | -0.013 | 3.899 | -0.261 |
| EBITDA Ratio
| 0.117 | 0.172 | 0.145 | 0.208 | 0.308 | 0.094 | 0.138 | 0.042 | -0.051 |